| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 3, 1260-1269, Copyright © 1992 by American Society of Nephrology
REGULAR ARTICLES |
VJ Savin, R Sharma, HB Lovell and DJ Welling
Department of Medicine, University of Kansas Medical Center, Kansas City 66103.
Macromolecular permeability of the glomerular capillary has been inferred from the clearance of endogenous protein or infused macromolecules. Permeability is increased after treatment with polycations as well as after renal injury. It has previously been shown that the capillaries of glomeruli isolated from normal mammals expand or collapse in response to transcapillary albumin gradients and that the magnitude of the changes in capillary volume and in total glomerular volume are directly proportional to the applied oncotic gradients. In the experiments presented here, the volume responses of control glomeruli and of glomeruli treated with protamine (100 to 600 micrograms/mL for up to 60 min) were used to calculate the albumin reflection coefficient, sigma albumin, and the convectional permeability, P convectional albumin = (1 - sigma albumin), of the capillary wall. Sigma albumin for normal glomeruli was about 1 (P convectional albumin = 0); sigma albumin fell to a minimum of 0.2 +/- 0.1 (P convectional albumin = 0.8 +/- 0.1) after incubation with protamine sulfate (600 micrograms/mL) for 30 min. Retraction and fusion of podocyte foot processes and denudation of the underlying matrix was seen on scanning electron micrographs of protamine-treated glomeruli. These results confirm that it is possible to study macromolecular permeability of the glomerular capillary in vitro and to calculate sigma albumin independent of hemodynamic and systemic humoral influences. This method will permit the assessment of the effects of individual mediators of glomerular injury and the study of glomeruli from kidneys affected by experimentally induced or naturally occurring renal diseases.
This article has been cited by other articles:
![]() |
J. M. Williams, A. Sarkis, K. M. Hoagland, K. Fredrich, R. P. Ryan, C. Moreno, B. Lopez, J. Lazar, F. J. Fenoy, M. Sharma, et al. Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1764 - F1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Haraldsson, J. Nystrom, and W. M. Deen Properties of the Glomerular Barrier and Mechanisms of Proteinuria Physiol Rev, April 1, 2008; 88(2): 451 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Williams, M. Sharma, S. Anjaiahh, J. R. Falck, and R. J. Roman Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier Am J Physiol Renal Physiol, August 1, 2007; 293(2): F501 - F505. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Datta, M. Sharma, P. Duann, and E. A. Lianos Effect of Nitric Oxide Synthase Inhibition on Proteinuria in Glomerular Immune Injury. Experimental Biology and Medicine, May 1, 2006; 231(5): 576 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Duann, P. K. Datta, C. Pan, J. B. Blumberg, M. Sharma, and E. A. Lianos Superoxide Dismutase Mimetic Preserves the Glomerular Capillary Permeability Barrier to Protein J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1249 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. J. Salmon, C. R. Neal, D. O. Bates, and S. J. Harper Vascular endothelial growth factor increases the ultrafiltration coefficient in isolated intact Wistar rat glomeruli J. Physiol., January 1, 2006; 570(1): 141 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Dahly-Vernon, M. Sharma, E. T. McCarthy, V. J. Savin, S. R. Ledbetter, and R. J. Roman Transforming Growth Factor-{beta}, 20-HETE Interaction, and Glomerular Injury in Dahl Salt-Sensitive Rats Hypertension, April 1, 2005; 45(4): 643 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carraro, C. Zennaro, M. Artero, G. Candiano, G. M. Ghiggeri, L. Musante, C. Sirch, M. Bruschi, and L. Faccini The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis Nephrol. Dial. Transplant., August 1, 2004; 19(8): 1969 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Ghiggeri, M. Carraro, and F. Vincenti Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1036 - 1040. [Full Text] [PDF] |
||||
![]() |
M. Sharma, R. Sharma, E. T. McCarthy, and V. J. Savin The Focal Segmental Glomerulosclerosis Permeability Factor: Biochemical Characteristics and Biological Effects Experimental Biology and Medicine, January 1, 2004; 229(1): 85 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carraro, C. Zennaro, G. Candiano, L. Musante, M. Bruschi, G. M. Ghiggeri, M. Artero, and L. Faccini Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome Nephrol. Dial. Transplant., April 1, 2003; 18(4): 689 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cattran, T. Neogi, R. Sharma, E. T. McCarthy, and V. J. Savin Serial Estimates of Serum Permeability Activity and Clinical Correlates in Patients with Native Kidney Focal Segmental Glomerulosclerosis J. Am. Soc. Nephrol., February 1, 2003; 14(2): 448 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Glassock Circulating Permeability Factors in the Nephrotic Syndrome: A Fresh Look at an Old Problem J. Am. Soc. Nephrol., February 1, 2003; 14(2): 541 - 543. [Full Text] [PDF] |
||||
![]() |
M. Carraro, G. Caridi, M. Bruschi, M. Artero, R. Bertelli, C. Zennaro, L. Musante, G. Candiano, F. Perfumo, and G. M. Ghiggeri Serum Glomerular Permeability Activity in Patients with Podocin Mutations (NPHS2) and Steroid-ResistantNephrotic Syndrome J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1946 - 1952. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sharma, M. Sharma, P. K. Datta, and V. J. Savin Induction of Metallothionein-I Protects Glomeruli from Superoxide-Mediated Increase in Albumin Permeability Experimental Biology and Medicine, January 1, 2002; 227(1): 26 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Li, J. Yao, T. Morioka, and T. Oite Nitric Oxide Increases Albumin Permeability of Isolated Rat Glomeruli via a Phosphorylation-Dependent Mechanism J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2616 - 2624. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fabris, R. Candido, M. Carraro, F. Fior, M. Artero, C. Zennaro, M. R. Cattin, A. Fiorotto, M. Bortoletto, C. Millevoi, et al. Modulation of Incipient Glomerular Lesions in Experimental Diabetic Nephropathy by Hypotensive and Subhypotensive Dosages of an ACE Inhibitor Diabetes, November 1, 2001; 50(11): 2619 - 2624. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Ghiggeri, M. Artero, M. Carraro, and F. Perfumo Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor Nephrol. Dial. Transplant., May 1, 2001; 16(5): 882 - 885. [Full Text] [PDF] |
||||
![]() |
G. CANDIANO, L. MUSANTE, M. CARRARO, L. FACCINI, L. CAMPANACCI, C. ZENNARO, M. ARTERO, F. GINEVRI, F. PERFUMO, R. GUSMANO, et al. Apolipoproteins Prevent Glomerular Albumin Permeability Induced In Vitro by Serum from Patients with Focal Segmental Glomerulosclerosis J. Am. Soc. Nephrol., January 1, 2001; 12(1): 143 - 150. [Abstract] [Full Text] |
||||
![]() |
M. SHARMA, R. SHARMA, E. T. MCCARTHY, and V. J. SAVIN "The FSGS Factor": Enrichment and in Vivo Effectof Activity from Focal Segmental Glomerulosclerosis Plasma J. Am. Soc. Nephrol., March 1, 1999; 10(3): 552 - 561. [Abstract] [Full Text] |
||||
![]() |
V. J. Savin, R. Sharma, M. Sharma, E. T. McCarthy, S. K. Swan, E. Ellis, H. Lovell, B. Warady, S. Gunwar, A. M. Chonko, et al. Circulating Factor Associated with Increased Glomerular Permeability to Albumin in Recurrent Focal Segmental Glomerulosclerosis N. Engl. J. Med., April 4, 1996; 334(14): 878 - 883. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673